Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $128.35 | Total: $641.75 |
| 1 | 10 | $108.72 | Total: $1,087.20 |
| 1 | 25 | $92.11 | Total: $2,302.75 |
| 1 | 50 | $78.52 | Total: $3,926.00 |
| 1 | 100 | $67.95 | Total: $6,795.00 |
Overview
B220, an antiviral agent, inhibits the growth of HSV-1, HSV-2, and human cytomegalovirus (CMV).
Chemical Properties
| Molecular Formula | C20H22N4 |
| Molecular Weight | 318.42 |
| CAS Numbers | 112228-65-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CN(C)CCn1c2ccccc2c2nc3cc(C)c(C)cc3nc12 |
Storage and Handling
0C Short Term, -20C Long Term
References
Mohammed Homman, et al. Pharmaceutical formulation of B220 for topical treatment of herpes. EP 2489354 A1.